Study the Safety and Efficacy of Probiotics Use in Premature Infants

NCT01891604 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2017-05-12

No results posted yet for this study

Summary

Prophylactic enteral probiotics may enhance clinical markers and biomarkers of preterm infants' health, and may also play a role in reducing NEC and associated morbidity.

Conditions

  • Infant, Premature, Diseases

Interventions

DIETARY_SUPPLEMENT

breast milk with Bifidobacterium Longum subp. Infantis R0033

DIETARY_SUPPLEMENT

breast milk

Sponsors & Collaborators

  • Lallemand Health Solutions

    collaborator INDUSTRY
  • University of Manitoba

    lead OTHER

Eligibility

Max Age
2 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Primary Completion
2016-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01891604 on ClinicalTrials.gov